Kashlov et al. showed that while serum levels of RIPK3 were not significantly elevated at time of presentation in patients suffering from an ST-elevation myocardial infarction (STEMI), serum levels of RIPK3 were significantly elevated along with troponin-I 24 h after onset of STEMI symptoms and percutaneous coronary artery intervention. This evidence concerns the gene RIPK3 and ST Elevation Myocardial Infarction.